Onconetix, Inc. SEC filings ONCO

Onconetix, Inc. has 398 filings in SEC EDGAR's recent list, going back to Jul 15, 2019. Its latest annual report, Form ARS, was filed on Oct 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (material agreement). The company's fiscal year ends on December 31.

Onconetix, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 27, 2026 —
4 Insider transaction Apr 22, 2026 Apr 14, 2026
4 Insider transaction Apr 21, 2026 Apr 14, 2026
4 Insider transaction Apr 16, 2026 Apr 14, 2026
3 Initial insider ownership Apr 16, 2026 Apr 14, 2026
3 Initial insider ownership Mar 27, 2026 Mar 18, 2026
3 Initial insider ownership Mar 27, 2026 Mar 19, 2026
3 Initial insider ownership Dec 12, 2025 Dec 5, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Jul 16, 2025 Jul 14, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 16, 2025 —
4 Insider transaction Mar 25, 2025 Mar 23, 2025
3 Initial insider ownership Mar 7, 2025 Feb 24, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 14, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
4 Insider transaction Jan 22, 2025 Dec 20, 2024
4 Insider transaction Jan 22, 2025 Dec 20, 2024
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
3/A Filing Nov 1, 2024 Sep 24, 2024
SC 13D Ownership over 5% (active) Oct 1, 2024 —
SC 13D Ownership over 5% (active) Oct 1, 2024 —
4 Insider transaction Sep 30, 2024 Sep 26, 2024
4 Insider transaction Sep 30, 2024 Sep 26, 2024
4 Insider transaction Sep 30, 2024 Sep 26, 2024
4 Insider transaction Sep 30, 2024 Sep 26, 2024
4 Insider transaction Sep 30, 2024 Sep 26, 2024
SCHEDULE 13G Ownership over 5% (passive) Sep 27, 2024 —
3 Initial insider ownership Sep 26, 2024 Sep 24, 2024
SC 13D Ownership over 5% (active) Sep 26, 2024 —
4 Insider transaction Sep 26, 2024 Sep 24, 2024
4 Insider transaction Sep 26, 2024 Sep 24, 2024
SC 13G Ownership over 5% (passive) Sep 26, 2024 —
3 Initial insider ownership Jun 20, 2024 Jun 10, 2024
SC 13G/A Amended ownership over 5% (passive) Jun 10, 2024 —
4 Insider transaction Feb 21, 2024 Feb 16, 2024
3 Initial insider ownership Feb 16, 2024 Feb 8, 2024
3 Initial insider ownership Feb 16, 2024 Feb 6, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 26, 2024 —
3 Initial insider ownership Jan 3, 2024 Dec 15, 2023
SC 13G/A Amended ownership over 5% (passive) Jan 2, 2024 —
3 Initial insider ownership Dec 28, 2023 Dec 15, 2023
SC 13G Ownership over 5% (passive) Dec 28, 2023 —
3 Initial insider ownership Oct 10, 2023 Oct 4, 2023
3 Initial insider ownership Oct 10, 2023 Oct 4, 2023
SC 13D Ownership over 5% (active) Jun 29, 2023 —
4 Insider transaction Jun 1, 2023 May 31, 2023
4 Insider transaction Jun 1, 2023 May 31, 2023
4 Insider transaction Jun 1, 2023 May 31, 2023
4 Insider transaction Jun 1, 2023 May 31, 2023
4 Insider transaction May 11, 2023 May 9, 2023
4 Insider transaction May 11, 2023 May 9, 2023
4 Insider transaction May 11, 2023 May 9, 2023
SC 13D Ownership over 5% (active) Apr 13, 2023 —
4 Insider transaction Apr 12, 2023 Apr 10, 2023
SC 13G Ownership over 5% (passive) Feb 14, 2023 —
SC 13G Ownership over 5% (passive) Jan 31, 2023 —
4 Insider transaction Jan 30, 2023 Jan 26, 2023
3 Initial insider ownership Jan 17, 2023 Jan 13, 2023
SC 13G Ownership over 5% (passive) Jan 4, 2023 —
SC 13D Ownership over 5% (active) Nov 21, 2022 —
4 Insider transaction Nov 21, 2022 Nov 17, 2022
4 Insider transaction Nov 9, 2022 Nov 8, 2022
3 Initial insider ownership Nov 8, 2022 Nov 4, 2022
SC 13D Ownership over 5% (active) Aug 29, 2022 —
4 Insider transaction Aug 29, 2022 Aug 25, 2022
4 Insider transaction Aug 24, 2022 Aug 22, 2022
3 Initial insider ownership Aug 24, 2022 Aug 22, 2022
4 Insider transaction Aug 23, 2022 Aug 19, 2022
4 Insider transaction Aug 22, 2022 Aug 18, 2022
4 Insider transaction Aug 22, 2022 Aug 18, 2022
4 Insider transaction May 27, 2022 May 4, 2022
4 Insider transaction May 27, 2022 May 4, 2022
4 Insider transaction May 27, 2022 May 4, 2022
4 Insider transaction May 27, 2022 May 4, 2022
4 Insider transaction May 27, 2022 May 4, 2022
4 Insider transaction May 27, 2022 May 4, 2022
4 Insider transaction May 27, 2022 May 4, 2022
SC 13D Ownership over 5% (active) Mar 3, 2022 —
SC 13D Ownership over 5% (active) Mar 3, 2022 —
4 Insider transaction Feb 24, 2022 Feb 23, 2022
3 Initial insider ownership Feb 23, 2022 Feb 23, 2022
3 Initial insider ownership Feb 17, 2022 Feb 17, 2022
3 Initial insider ownership Feb 17, 2022 Feb 17, 2022
3 Initial insider ownership Feb 17, 2022 Feb 17, 2022
3 Initial insider ownership Feb 17, 2022 Feb 17, 2022
3 Initial insider ownership Feb 17, 2022 Feb 17, 2022
3 Initial insider ownership Feb 17, 2022 Feb 17, 2022
3 Initial insider ownership Feb 17, 2022 Feb 17, 2022
3 Initial insider ownership Feb 17, 2022 Feb 17, 2022

Showing 95 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ONCO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cincinnati, OH
SEC filer status
, Emerging growth company
SEC CIK
1782107
Former names
Blue Water Biotech, Inc. (until Dec 18, 2023); Blue Water Vaccines Inc. (until Apr 20, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.